Our Story

PanGenomic has developed a health-tech platform to provide further personal control over mental health treatments.

Our personalized insight system helps connect individuals and healthcare practitioners with precision natural remedy options.


Featured stats


Or nearly 200 million people will experience mental illness during their lifetime.

1 in 5 adults

Experienced mental illness in 2020 in U.S. That is 52.9 million people.

26.3 millions

Adults in U.S. received virtual mental health services in the past year.

who we are

PanGenomic is a public benefit company, redefining mental health

We are PanGenomic, and our mission is to improve the health and wellness of people through a technology platform that identifies plant-based solutions tailored to the health profile of every individual.

We believe that mental health is just as important as physical health. But the pharmaceutical industry is structured to find a pill for every health condition. PanGenomic believes a more personable and natural approach is needed to address mental health challenges.

Our self-care platform is designed to provide the necessary tools for keeping your mind and body in sync. We give you the insights, information, and understanding and let you take it from there.

We believe the pursuit of profit can be aligned with effecting positive change for people and the planet. To meet this vision, PanGenomic registered as one of Canada’s first public benefit corporations.

Trusted by

We wouldn't be where we are now, if not for our amazing partner brands.


Meet the PanGenomic Team

Maryam has served in almost every facet of business: founder, board member, consultant, and CEO. Her drive for excellence has seen her master skills in consumer product marketing, private clinical services, public relations, and social advocacy; however, healthcare remains a central passion.
Maryam Marissen
Robert co-founded the biotechnology company Havn Life Sciences (CSE :HAVN) and was a founding director of Psy Integrated Health Corp and its Empower Health Vancouver clinic. Robert also co-founded the ETC3 Tech Centre in the Research Campus of UBC. Previously, Robert was CEO of Epic Data and CEO of Fincentric.
Robert Nygren
Vincent has over 20 years of experience in the life sciences industry holding various C level operating positions. Vincent cofounded Cardio-digital which was subsequently sold to Medtronic. He was previously vice president and partner at MDS Capital and Royal Bank Venture capital.
Vincent Lum
Colin is CEO of Excelar which develops health predictive analytics platforms and Chatnels, an augmented intelligence clinical messaging platform. Previously, Colin founded EQO, and held executive roles at Nortel, Telos, and Global Relay. Colin holds an MBA from University of British Columbia and BASc. Electrical Engineering from Simon Fraser University.
Colin Quon
Kaidong was trained in protein engineering and medicinal chemistry and has 15 years of life science experience in academia and industry. Recent R&D projects include clinical diagnosis development, integrative medicine-based chronic disease management, nutraceutical product development, and non-invasive diagnostic/therapeutic devices to manage chronic prostate disease and non-alcoholic fatty liver diseases.
Kaidong Zhang
Tammy has 20 years’ experience in the public markets bringing comprehensive background in finance, reporting and regulatory requirements for manufacturing, bio-technology, technology and junior exploration industries. She has been part of teams that have completed financings, grant applications and acquisition transactions. Tammy has served as officer for several listed issuers.
Tammy Gillis
Bin has over 20 years C-suite experience leading public life sciences companies in North America and Asia, most recently as CEO of Emerald Health Therapeutics Inc. and WEX Pharmaceuticals Inc. She has also acted as a director of a number of Canadian biotechnology companies and industry associations.
Bin Huang
Peter has extensive leadership experience in the cloud technologies, AI, mobile and telecommunications sectors. Peter was President of the Cable and Wireless Company in the UK and later served as SVP and President of TELUS Business. Peter currently serves as an independent director of Fobi AI Inc. (TSX.V:FOBI).
Peter Green
Jonathan has substantial experience in the video game industry, having served in various executive management positions at Electronic Arts (EA) since 1998. He recently had responsibility for Corporate Strategy, CTO Finance and Strategy, Operations & Finance leadership for EA’s Strategic Growth Division. Jonathan previously served as CFO of EA Canada.
Jonathan Lutz
John-Peter is a socially responsible entrepreneur and has served as CEO, Executive Chair, board member and strategic/investment advisor in cannabis, psychedelic medicine, telecommunications, resource, and oncology companies, both public and private. He has substantive understanding of compliance, distribution, governance, medical regulatory and research matters.
John-Peter Bradford
Malcolm is CEO of Microbiome Insights Inc., a provider of microbiome DNA sequencing and bioinformatic analysis services. Malcolm has over three decades of operational management, entrepreneurial, venture capital investment and leadership experience, the majority of which has been focused on company creation and building value in technology and biotechnology companies.
Malcolm Kendall
Patrick is an ethnobotanist, herbalist and wildcrafter living in Nelson, BC. He is co-owner and founder of Blue Lotus Ethnobotanicals, a provider of handcrafted herbal tinctures, syrups and salves made using ethically wildcrafted and organic ingredients, as well as culinary mushrooms and other non-timber forest products.
Patrick Kooyman
MSc, Master Herbalist